Linda McCardle

4.2k total citations · 1 hit paper
19 papers, 3.0k citations indexed

About

Linda McCardle is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Linda McCardle has authored 19 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Neurology and 4 papers in Neurology. Recurrent topics in Linda McCardle's work include Prion Diseases and Protein Misfolding (18 papers), Neurological diseases and metabolism (7 papers) and Alcoholism and Thiamine Deficiency (4 papers). Linda McCardle is often cited by papers focused on Prion Diseases and Protein Misfolding (18 papers), Neurological diseases and metabolism (7 papers) and Alcoholism and Thiamine Deficiency (4 papers). Linda McCardle collaborates with scholars based in United Kingdom, United States and Poland. Linda McCardle's co-authors include James W. Ironside, Robert Will, Simon Cousens, D. Drummond, Christopher J. Bostock, I. McConnell, M. E. Bruce, Christopher R. Birkett, A. Chree and Jayne C. Hope and has published in prestigious journals such as Nature, Annals of Neurology and American Journal Of Pathology.

In The Last Decade

Linda McCardle

19 papers receiving 2.9k citations

Hit Papers

Transmissions to mice indicate that ‘new variant’ CJD is ... 1997 2026 2006 2016 1997 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda McCardle United Kingdom 17 2.9k 1.2k 689 211 131 19 3.0k
A. Chree United Kingdom 7 2.1k 0.7× 989 0.8× 604 0.9× 91 0.4× 57 0.4× 8 2.2k
H. Diringer Germany 26 2.8k 1.0× 1.3k 1.0× 1.3k 1.8× 193 0.9× 168 1.3× 56 3.0k
Richard F. Marsh United States 29 3.0k 1.0× 1.5k 1.2× 1.3k 1.8× 139 0.7× 181 1.4× 66 3.3k
D. Drummond United Kingdom 7 1.5k 0.5× 660 0.5× 436 0.6× 60 0.3× 44 0.3× 9 1.6k
G. A. H. Wells United Kingdom 23 1.7k 0.6× 1.0k 0.8× 544 0.8× 59 0.3× 28 0.2× 41 1.9k
Fiona Houston United Kingdom 18 1.3k 0.5× 502 0.4× 488 0.7× 44 0.2× 43 0.3× 34 1.4k
Marion M. Simmons United Kingdom 22 1.5k 0.5× 750 0.6× 548 0.8× 31 0.1× 43 0.3× 74 1.6k
G.C. Millson United States 21 1.2k 0.4× 327 0.3× 498 0.7× 57 0.3× 78 0.6× 47 1.4k
Karim Tarik Adjou France 19 835 0.3× 422 0.3× 335 0.5× 65 0.3× 117 0.9× 42 1.1k
Nathaniel D. Denkers United States 19 852 0.3× 183 0.1× 140 0.2× 27 0.1× 40 0.3× 27 1.0k

Countries citing papers authored by Linda McCardle

Since Specialization
Citations

This map shows the geographic impact of Linda McCardle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda McCardle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda McCardle more than expected).

Fields of papers citing papers by Linda McCardle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda McCardle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda McCardle. The network helps show where Linda McCardle may publish in the future.

Co-authorship network of co-authors of Linda McCardle

This figure shows the co-authorship network connecting the top 25 collaborators of Linda McCardle. A scholar is included among the top collaborators of Linda McCardle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda McCardle. Linda McCardle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gill, O Nöel, Y. I. Spencer, Angela Richard-Loendt, et al.. (2020). Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic. Acta Neuropathologica. 139(6). 965–976. 23 indexed citations
2.
Peden, Alexander, Linda McCardle, Mark Head, et al.. (2010). Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia. 16(2). 296–304. 175 indexed citations
3.
Clewley, Jonathan P., Catherine M. Kelly, Nick Andrews, et al.. (2009). Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ. 338(may21 2). b1442–b1442. 68 indexed citations
4.
Ironside, James W., Matthew Bishop, Doha Hegazy, et al.. (2006). Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ. 332(7551). 1186–1188. 107 indexed citations
5.
Hilton, David A., Mark Penney, P. G. Edwards, et al.. (2004). Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease. Journal of Clinical Pathology. 57(3). 300–302. 51 indexed citations
6.
Head, Mark, Diane Ritchie, William H. Nailon, et al.. (2004). Peripheral Tissue Involvement in Sporadic, Iatrogenic, and Variant Creutzfeldt-Jakob Disease. American Journal Of Pathology. 164(1). 143–153. 133 indexed citations
7.
Hilton, David A., Azra C. Ghani, P. G. Edwards, et al.. (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. The Journal of Pathology. 203(3). 733–739. 293 indexed citations
8.
Head, Mark, Tristan Bunn, Matthew Bishop, et al.. (2004). Prion protein heterogeneity in sporadic but not variant Creutzfeldt–Jakob disease: U.K. cases 1991–2002. Annals of Neurology. 55(6). 851–859. 112 indexed citations
9.
Head, Mark, Diane Ritchie, Linda McCardle, et al.. (2003). Prion Protein Accumulation in Eyes of Patients with Sporadic and Variant Creutzfeldt-Jakob Disease. Investigative Ophthalmology & Visual Science. 44(1). 342–342. 74 indexed citations
10.
Ironside, James W., et al.. (2002). Pathological diagnosis of variant Creutzfeldt‐Jakob disease. Apmis. 110(1). 79–87. 57 indexed citations
11.
Kovács, Gábor G., Mark Head, Ivan Hegyi, et al.. (2002). Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes. Brain Pathology. 12(1). 1–11. 86 indexed citations
12.
Liberski, Paweł P., et al.. (2000). Ultrastructural analysis of the florid plaque in variant Creutzfeldt-Jakob disease.. PubMed. 38(4). 167–70. 12 indexed citations
13.
Ironside, James W., Mark Head, J. E. Bell, Linda McCardle, & Robert Will. (2000). Laboratory diagnosis of variant Creutzfeldt–Jakob disease. Histopathology. 37(1). 1–9. 116 indexed citations
14.
Richard, M., et al.. (1999). Protection of personnel and environment against Creutzfeldt-Jakob disease in pathology laboratories.. PubMed. 47(3-4). 192–200. 10 indexed citations
15.
Bruce, M. E., Robert Will, James W. Ironside, et al.. (1997). Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature. 389(6650). 498–501. 1485 indexed citations breakdown →
16.
Bell, Jeanne E., Steve Gentleman, James W. Ironside, et al.. (1997). Prion protein immunocytochemistry – UK five centre consensus report. Neuropathology and Applied Neurobiology. 23(1). 26–35. 98 indexed citations
17.
Ironside, James W., J. E. Bell, Linda McCardle, et al.. (1996). . Cold Spring Harbor Symposia on Quantitative Biology. 61(1). 523–530. 50 indexed citations
18.
Silva, Rajith de, James W. Ironside, Linda McCardle, et al.. (1994). Neuropathological phenotype and ‘prion protein’ genotype correlation in sporadic Creutzfeldt-Jakob disease. Neuroscience Letters. 179(1-2). 50–52. 28 indexed citations
19.
Ironside, James W., et al.. (1993). Ubiquitin immunocytochemistry in human spongiform encephalopathies. Neuropathology and Applied Neurobiology. 19(2). 134–140. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026